two new drugs for hepatitis C, Incivek (telaprevir, in-SEE-veck) and Victrelis (boceprevir, vic-TREL-is)

August 2011

You'll hear about two new drugs for hepatitis C, Incivek (telaprevir, in-SEE-veck) and Victrelis (boceprevir, vic-TREL-is).

Hepatitis C is a viral infection that affects the liver...and often leads to chronic liver disease, cirrhosis, and liver cancer.

Victrelis and Incivek are "game changers"...and are bringing up new talks about finally "curing" hepatitis C.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Erectile Dysfunction avoiding errors when dispensing erectile dysfunction meds (Viagra, Cialis, etc)
Vitamins & Minerals dispensing vitamin B12 supplements
Hepatitis C two new drugs for hepatitis C, Incivek (telaprevir, in-SEE-veck) and Victrelis (boceprevir, vic-TREL-is)
Statins if statins increase the risk of diabetes
Sunscreens New rules for sunscreens
Thrush Topical antifungals for oral thrush
Antibiotics which oral erythromycin to dispense
Medication Errors new checks and balances to avoid mishaps with risperidone (Risperdal) and ropinirole (Requip)
Education and Training a new electronic CE reporting system called CPE Monitor
Smoking Cessation new warnings about Chantix and an increased risk of heart troubles in patients with heart disease
Cardiology two new blood thinners, Brilinta (ticagrelor, tye-KA-grel-or) and Xarelto (rivaroxaban, zuh-REL-toe)
Dispensing how to handle Rxs for butalbital-containing meds (Fiorinal, Fioricet, Esgic-Plus, etc)